On the HCPLive multiple sclerosis page, resources on the topics of medical news and expert insight into MS can be found. Content includes articles, interviews, videos, podcasts, and breaking news on primary progress and relapsing-remitting multiple sclerosis, and more.
December 9th 2022
As the treatment paradigm for neurologic diseases rapidly progresses, the need for more thorough biomarker tools to measure disease progression and severity has increased. In recent years, GFAP has emerged as a valuable candidate to add to the existing panel.
MRIs May Be Able to Detect Patients at Risk for Developing Multiple Sclerosis
Results from a study published in the International Journal of MS Care suggest that magnetic resonance imaging may be used to identify asymptomatic patients who are at higher risk for developing multiple sclerosis.
Tales of the Anion Gap, Part III: Case Examples
October 21st 2014Calculation and interpretation of the anion gap is extremely useful in the evaluation and treatment of the patient with metabolic acidosis. In this installment, we look at case examples involving patients with multiple sclerosis and urosepsis; COPD, diabetes, and renal failure; and type 1 diabetes.
FDA Oks Label Change for MS drug
The US Food and Drug Administration (FDA) approved Genzyme's application to include new information about its multiple sclerosis drug teriflunomide (Aubagio) on its label. The new labeling content is efficacy and safety data from two Phase III trials of the drug.